With the recent approvals in U.K. and U.S. to bring embryonic stem-cell therapies to clinical trials, this has emboldened other companies such as Pfizer to follow suit and enter ethically-murky waters of embryonic stem-cell therapies....
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)